Development of Medical Countermeasures for Biodefense and Emerging Infectious Diseases
Past New Requirement Updated
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $1,500,000 to $3,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services National Institutes of Health (NIH) is forecasting a new contract opportunity for the development of medical countermeasures focused on biodefense and emerging infectious diseases. The contract, with an estimated award date of December 1, 2024, falls under the Research and Development in Biotechnology NAICS category (541714). The primary objective appears to be advancing scientific research and technological solutions for medical preparedness against potential biological threats.
While specific award values are not disclosed, the opportunity is categorized with no set-aside, suggesting open competition among qualified biotechnology research and development firms. Key points of contact include Alexandra Buck, a Contract Specialist (alexandra.buck@nih.gov, 301-402-6289), and Paul Eder, a Senior Scientific Officer at NIH. The contract will likely involve complex research protocols, potential laboratory work, and innovative approaches to developing medical countermeasures, with the work to be performed within NIH's research facilities or associated research environments.
Forecast text
Development of Medical Countermeasures for Biodefense and Emerging Infectious Diseases
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast